Abstract
Purpose
The human Y chromosome plays a central role in sex determination and spermatogenesis. The azoospermia factor (AZF) loci on the Y chromosome contain genes that were thought to be testis specific with their deletions leading to spermatogenic failure. However, beyond the testis, the AZF genes (mainly those in AZFa and AZFb loci) are widely expressed in multiple tissues. Further, these genes are predicted to play roles in processes such as gene regulation and protein synthesis. These observations suggest that the AZF genes may have functions beyond regulation of fertility.
Results
Three major areas have emerged where alternations in AZF genes have effects beyond infertility. (1) Poor-quality embryos are generated in assisted reproduction when sperm from men harboring Y chromosome microdeletions are used, (2) a higher preponderance of neuropsychiatry disorders is observed in men with deletions in AZF genes, and (3) copy number variations and altered expression of AZF genes are found in several cancers.
Conclusion
While our data is preliminary and observational in nature, systematic studies are required to address how genetic alterations in the Y chromosome can affect the health of men beyond infertility. This information will provide a different perspective in the area of androgenetics and have implications in devising strategies for maintaining the overall well-being of infertile males.
Similar content being viewed by others
References
Colaco S, Modi D. Genetics of the human Y chromosome and its association with male infertility. Reprod Biol Endocrinol. 2018;16:14.
Maan AA, Eales J, Akbarov A, Rowland J, Xu X, Jobling MA, et al. The Y chromosome: a blueprint for men’s health? Eur J Hum Genet. 2017;25:1181.
Jangravi Z, Alikhani M, Arefnezhad B, Sharifi Tabar M, Taleahmad S, Karamzadeh R, et al. A fresh look at the male-specific region of the human Y chromosome. J Proteome Res. 2012;12:6–22.
Vogt PH, Bender U, Zimmer J, Strowitzki T. Human Y chromosome and male infertility: forward and back from azoospermia factor chromatin structure to azoospermia factor gene function. In: Genetics of human infertility: Karger Publishers; 2017. p. 57–73.
Charlesworth B. The organization and evolution of the human Y chromosome. Genome Biol. 2003;4:226.
Skaletsky H, Kuroda-Kawaguchi T, Minx PJ, Cordum HS, Hillier L, Brown LG, et al. The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature. 2003;423:825–37.
Hughes JF, Page DC. The biology and evolution of mammalian Y chromosomes. Annu Rev Genet. 2015;49:507–27.
Vergnaud G, Page DC, Simmler MC, Brown L, Rouyer F, Noel B, et al. A deletion map of the human Y chromosome based on DNA hybridization. Am J Hum Genet. 1986;38:109–24.
Vollrath D, Foote S, Hilton A, Brown LG, Beer-Romero P, Bogan JS, et al. The human Y chromosome: a 43-interval map based on naturally occurring deletions. Science. 1992;258:52–60.
Vogt PH. Human Y chromosome function in male germ cell development. In: Advances in developmental biology: Academic Press; 1996. p. 191–257.
Navarro-Costa P, Plancha CE, Gonçalves J. Genetic dissection of the AZF regions of the human Y chromosome: thriller or filler for male (in)fertility? J Biomed Biotechnol. 2010;2010:936569.
Sen S, Pasi AR, Dada R, Shamsi MB, Modi D. Y chromosome microdeletions in infertile men: prevalence, phenotypes and screening markers for the Indian population. J Assist Reprod Genet. 2013;30:413–22.
Navarro-Costa P, Gonçalves J, Plancha CE. The AZFc region of the Y chromosome: at the crossroads between genetic diversity and male infertility. Hum Reprod Update. 2010;16:525–42.
Bansal SK, Jaiswal D, Gupta N, Singh K, Dada R, Sankhwar SN, et al. gr/gr deletions on Y-chromosome correlate with male infertility: an original study, meta-analyses, and trial sequential analyses. Sci Rep. 2016;6:19798.
Sen S, Ambulkar P, Hinduja I, Zaveri K, Gokral J, Pal A, et al. Susceptibility of gr/gr rearrangements to azoospermia or oligozoospermia is dependent on DAZ and CDY1 gene copy deletions. J Assist Reprod Genet. 2015;32:1333–41.
Noordam MJ, Westerveld GH, Hovingh SE, van Daalen SK, Korver CM, van der Veen F, et al. Gene copy number reduction in the azoospermia factor c (AZFc) region and its effect on total motile sperm count. Hum Mol Genet. 2011;20:2457–63.
Wei W, Fitzgerald T, Ayub Q, Massaia A, Smith BB, Dominiczak AA, et al. Copy number variation in the human Y chromosome in the UK population. Hum Genet. 2015;134:789–800.
Massaia A, Xue Y. Human Y chromosome copy number variation in the next generation sequencing era and beyond. Hum Genet. 2017;136:591–603.
Premi S, Srivastava J, Epplen JT, Ali S. AZFc region of the Y chromosome shows singular structural organization. Chromosome Res. 2010;18:419–30.
Kumari A, Yadav SK, Ali S. Organizational and functional status of the Y-linked genes and loci in the infertile patients having normal spermiogram. PLoS One. 2012;7:e41488.
Rozen SG, Marszalek JD, Irenze K, Skaletsky H, Brown LG, Oates RD, et al. AZFc deletions and spermatogenic failure: a population-based survey of 20,000 Y chromosomes. Am J Hum Genet. 2012;91:890–6.
Giacco DL, Chianese C, Sánchez-Curbelo J, Bassas L, Ruiz P, Rajmil O, et al. Clinical relevance of Y-linked CNV screening in male infertility: new insights based on the 8-year experience of a diagnostic genetic laboratory. Eur J Hum Genet. 2014;22:754.
Case LK, Wall EH, Osmanski EE, Dragon JA, Saligrama N, Zachary JF, et al. Copy number variation in Y chromosome multicopy genes is linked to a paternal parent-of-origin effect on CNS autoimmune disease in female offspring. Genome Biol. 2015;16:28.
Yan Y, Yang X, Liu Y, Shen Y, Tu W, Dong Q, et al. Copy number variation of functional RBMY1 is associated with sperm motility: an azoospermia factor-linked candidate for asthenozoospermia. Hum Reprod. 2017;32:1521–31.
Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Tissue-based map of the human proteome. Science. 2015;347:1260419.
The UniProt Consortium. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 2017;45:D158–69.
Zeng M, Sun H, Chen S, Wang X, Yang Y, Liu Y, et al. Identification of target messenger RNA substrates for mouse RBMY. Mol Hum Reprod. 2008;14:331–6.
Zeng M, Liang S, Zhao S, Liu Y, Sun H, Zhang S, et al. Identifying mRNAs bound by human RBMY protein in the testis. J Reprod Dev. 2011;57:107–12.
Gozdecka M, Meduri E, Mazan M, Tzelepis K, Dudek M, Knights AJ, et al. UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through non-catalytic inverse regulation of ETS and GATA programs. Nat Genet. 2018;50:883–94.
Rosinski KV, Fujii N, Mito JK, Koo KKW, Xuereb SM, Sala-Torra O, et al. DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells. Blood. 2008;111:4817–26.
Sun AG, Wang J, Shan YZ, Yu WJ, Li X, Cong CH, et al. Identifying distinct candidate genes for early Parkinson’s disease by analysis of gene expression in whole blood. Neuro Endocrinol Lett. 2014;35:398–404.
Tian Y, Stamova B, Jickling GC, Xu H, Liu D, Ander BP, et al. Y chromosome gene expression in the blood of male patients with ischemic stroke compared with male controls. Gend Med. 2012;9:68–75.
Yu A, Zhang J, Liu H, Liu B, Meng L. Identification of non-diabetic heart failure-associated genes by bioinformatics approaches in patients with dilated ischemic cardiomyopathy. Exp Ther Med. 2016;11:2602–8.
Komura K, Jeong SH, Hinohara K, Qu F, Wang X, Hiraki M, et al. Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression. Proc Natl Acad Sci U S A. 2016;113:6259–64.
Komura K, Yoshikawa Y, Shimamura T, Chakraborty G, Gerke TA, Hinohara K, et al. ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D. J Clin Invest. 2018;128:2979–95.
Zhu Y, Ren S, Jing T, Cai X, Liu Y, Wang F, et al. Clinical utility of a novel urine-based gene fusion TTTY15-USP9Y in predicting prostate biopsy outcome. In: Urologic oncology: seminars and original investigations, vol. 33; 2015. p. 384–e9.
Bloomer LD, Nelson CP, Eales J, Denniff M, Christofidou P, Debiec R, et al. Male-specific region of the Y chromosome and cardiovascular risk: phylogenetic analysis and gene expression studies. Arterioscler Thromb Vasc Biol. 2013;33:1722–7.
Tsuei DJ, Lee PH, Peng HY, Lu HL, Su DS, Jeng YM, et al. Correction: male germ cell-specific RNA binding protein RBMY: a new oncogene explaining male predominance in liver cancer. PLoS One. 2012;7.
Kumar AS, Seah MK, Ling KY, Wang Y, Tan JH, Nitsch S, et al. Loss of maternal Trim28 causes male-predominant early embryonic lethality. Genes Dev. 2017;31:12–7.
Chua HH, Tsuei DJ, Lee PH, Jeng YM, Lu J, Wu JF, et al. RBMY, a novel inhibitor of glycogen synthase kinase 3β, increases tumor stemness and predicts poor prognosis of hepatocellular carcinoma. Hepatology. 2015;62:1480–96.
Zhu XB, Liu YL, Zhang W, Ping P, Cao XR, Liu Y, et al. Vertical transmission of the Yq AZFc microdeletion from father to son over two or three generations in infertile Han Chinese families. Asian J Androl. 2010;12:240–6.
Page DC, Silber S, Brown LG. Men with infertility caused by AZFc deletion can produce sons by intracytoplasmic sperm injection, but are likely to transmit the deletion and infertility. Hum Reprod. 1999;14:1722–6.
Choi JM, Chung P, Veeck L, Mielnik A, Palermo GD, Schlegel PN. AZF microdeletions of the Y chromosome and in vitro fertilization outcome. Fertil Steril. 2004;81:337–41.
Colaco S, Sakkas D. Paternal factors contributing to embryo quality. J Assist Reprod Genet. 2018;35:1953–68.
Mulhall JP, Reijo R, Alagappan R, Brown L, Page D, Carson R, et al. Azoospermic men with deletion of the DAZ gene cluster are capable of completing spermatogenesis: fertilization, normal embryonic development and pregnancy occur when retrieved testicular spermatozoa are used for intracytoplasmic sperm injection. Hum Reprod. 1997;12:503–8.
van Golde RJ, Wetzels AM, de Graaf R, Tuerlings JH, Braat DD, Kremer JA. Decreased fertilization rate and embryo quality after ICSI in oligozoospermicmen with microdeletions in the azoospermia factor c region of the Y chromosome. Hum Reprod. 2001;16:289–92.
Beyaz CC, Gunes S, Onem K, Kulac T, Asci R. Partial deletions of Y-chromosome in infertile men with non-obstructive azoospermia and oligoasthenoteratozoospermia in a Turkish population. In Vivo. 2017;31:365–71.
Gonçalves C, Cunha M, Rocha E, Fernandes S, Silva J, Ferraz L, et al. Y-chromosome microdeletions in nonobstructive azoospermia and severe oligozoospermia. Asian J Androl. 2017;19:338.
Kihaile PE, Yasui A, Shuto Y. Prospective assessment of Y-chromosome microdeletions and reproductive outcomes among infertile couples of Japanese and African origin. Journal of Experimental & Clinical Assisted Reproduction. 2005;2:9.
Mateu E, Rodrigo L, Martínez MC, Peinado V, Milán M, Gil-Salom M, et al. Aneuploidies in embryos and spermatozoa from patients with Y chromosome microdeletions. Fertil Steril. 2010;94:2874–7.
Patsalis PC, Sismani C, Quintana-Murci L, Krausz C, McElreavey K. Effects of transmission of Y chromosome AZFc deletions. Lancet. 2002;360:1222–4.
Rajpert De Meyts E, Ottesen AM, Garn ID, Aksglaede L, Juul A. Deletions of the Y chromosome are associated with sex chromosome aneuploidy but not with Klinefelter syndrome. Acta Paediatr. 2011;100:900–2.
Boroviak T, Stirparo GG, Dietmann S, Hernando-Herraez I, Mohammed H, Reik W, et al. Single cell transcriptome analysis of human, marmoset and mouse embryos reveals common and divergent features of preimplantation development. Development. 2018;145:dev167833.
Modi D, Bhartiya D. Y chromosome mosaicism and occurrence of gonadoblastoma in cases of Turner syndrome and amenorrhoea. Reprod Biomed Online. 2007;15:547–53.
Jørgensen A, Johansen ML, Juul A, Skakkebaek NE, Main KM, Rajpert-De Meyts E. Pathogenesis of germ cell neoplasia in testicular dysgenesis and disorders of sex development. Semin Cell Dev Biol. 2015;45:124–37.
Huang H, Wang C, Tian Q. Gonadal tumour risk in 292 phenotypic female patients with disorders of sex development containing Y chromosome or Y-derived sequence. Clin Endocrinol (Oxf). 2017;86:621–7.
Noveski P, Madjunkova S, Stefanovska ES, Geshkovska NM, Kuzmanovska M, Dimovski A, et al. Loss of Y chromosome in peripheral blood of colorectal and prostate cancer patients. PLoS One. 2016;11:e0146264.
Nathanson KL, Kanetsky PA, Hawes R, Vaughn DJ, Letrero R, Tucker K, et al. The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet. 2005;77:1034–43.
Dutta A, Le Magnen C, Mitrofanova A, Ouyang X, Califano A, Abate-Shen C. Identification of an NKX3. 1-G9a-UTY transcriptional regulatory network that controls prostate differentiation. Science. 2016;352:1576–80.
Li N, Dhar SS, Chen TY, Kan PY, Wei Y, Kim JH, et al. JARID1D is a suppressor and prognostic marker of prostate cancer invasion and metastasis. Cancer Res. 2016;76:831–4.
Moreno-Mendoza D, Casamonti E, Paoli D, Chianese C, Riera-Escamilla A, Giachini C, Fino MG, Cioppi F, Lotti F, Vinci S, Magini A. gr/gr deletion predisposes to testicular germ cell tumour independently from altered spermatogenesis: results from the largest European study. European Journal of Human Genetics. 2019;3:1.
Castro A, Rodríguez F, Flórez M, López P, Curotto B, Martínez D, et al. Pseudoautosomal abnormalities in terminal AZFb+c deletions are associated with isochromosomes Yp and may lead to abnormal growth and neuropsychiatric function. Hum Reprod. 2017;32:465–75.
Acknowledgments
DM lab is funded by grants from Indian Council of Medical Research (ICMR), Government of India. SC is thankful to ICMR for the postdoctoral fellowship. The manuscript bears the NIRRH ID: IR/702/11-2018.
This study makes use of data generated by the DECIPHER community. A full list of centers who contributed to the generation of the data is available from http://decipher.sanger.ac.uk and via email from decipher@sanger.ac.uk. Funding for the project was provided by The Wellcome Trust.
Tissue expression of the Y chromosome genes was retrieved from data sets in the Human Protein Atlas. Tissue distribution map of the Y chromosome genes was created using Morpheus, https://software.broadinstitute.org/morpheus.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 17 kb)
Rights and permissions
About this article
Cite this article
Colaco, S., Modi, D. Consequences of Y chromosome microdeletions beyond male infertility. J Assist Reprod Genet 36, 1329–1337 (2019). https://doi.org/10.1007/s10815-019-01492-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-019-01492-z